Sartorius Stedim Biotech SA

F:56S0

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 56S0's stock price target?

Price Target

24.35 EUR

According to Wall Street analysts, the average 1-year price target for 56S0 is 24.35 EUR with a low forecast of 21.1 EUR and a high forecast of 31.34 EUR.

What is the Revenue forecast for Sartorius Stedim Biotech SA?

Projected CAGR

10%

Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 10%.

What is the Gross Profit forecast for Sartorius Stedim Biotech SA?

Projected CAGR

13%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 3 years is 13%.

What is the Operating Income forecast for Sartorius Stedim Biotech SA?

Projected CAGR

23%

Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 23%.

What is the Pre-Tax Income forecast for Sartorius Stedim Biotech SA?

Projected CAGR

36%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 36%.

What is the Net Income forecast for Sartorius Stedim Biotech SA?

Projected CAGR

38%

Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 38%.